Home LiteratureArticle Details
PMID: 1167871 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.

The Journal of clinical investigation ·Vol. 55 ·No. 3 ·1975-03-00 ·Pages 587-92

Ruddy S, Austen KF, Goetzl EJ

Abstract

Interaction of D (the activated form of D) and B, factors of the properdin pathway, with C3b (the major cleavage fragment of C3) generates a convertase, C3B, which cleaves C3 and initiates the terminal complement sequence C5-C9. A functionally analogous more stable C3 convertase, CoVFB, ir formed by substituting cobra venom factor (CoVF) for C3b. Mixtures of highly purified CoVF, B, and D were chemotactic for human neutrophil polymorphonuclear leukocytes as assessed in Boyden chambers either by microscopic enumeration of migrating cells or by counting of 51Cr-labeled cells. Control mixtures containing CoVF, B, and D, reacted in the absence of Mg++, were hemolytically inactive and devoid of chemotactic activity. Over a range of doses, the chemotactic activity of mixtures yielding CoVFB correlated with their hemolytic activity. Pretreatment of neutrophils with mixtures containing CoVFB rendered them unresponsive to subsequent chemotactic stimulation by kallikrein of C5a, indicating cross-deactivation to other chemotactic factors. Similar neutrophil deactivation occurred after exposure to a mixture of C3b, B, and D in which C3B was formed; with short incubation times and high cell concentration C3B also exhibited some chemotactic activity. The chemotactic activity of C3B and CoVFB is an example of a biologic function arising from interactions among factors of the properdin pathway per se, as distinguished from the capacity of this pathway to activate C3 and the terminal complement sequence.

MeSH Terms
Animals Chemotaxis Complement System Proteins Humans Neutrophils/physiology Properdin/metabolism Rabbits/immunology Sheep/immunology Snake Venoms Venoms
Chemicals
Snake Venoms Venoms Properdin Complement System Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ruddy S
Austen K F
Goetzl E J
References (24)
24 references, click to expand
  1. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
    J Exp Med. 1965 Aug 1;122:327-46 PMID: 14316948
  2. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
    Immunochemistry. 1966 Mar;3(2):111-35 PMID: 5960883
  3. A method for assessing the in vitro chemotactic response of neutrophils utilizing 51cr-labeled human leukocytes.
    Immunol Commun. 1972;1(5):421-30 PMID: 4217768
  4. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
    J Exp Med. 1972 Jan;135(1):81-97 PMID: 5009705
  5. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.
    J Exp Med. 1972 Dec 1;136(6):1564-80 PMID: 4641855
  6. Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.
    J Exp Med. 1974 Mar 1;139(3):696-711 PMID: 4591176
  7. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    J Immunol. 1969 Nov;103(5):944-52 PMID: 4981797
  8. The C3-activator system: an alternate pathway of complement activation.
    J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s PMID: 4105810
  9. C3 proactivator convertase and its mode of action.
    J Exp Med. 1972 Apr 1;135(4):1003-8 PMID: 4111773
  10. A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.
    J Immunol. 1967 Dec;99(6):1162-72 PMID: 4168662
  11. Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.
    J Exp Med. 1973 Dec 1;138(6):1305-13 PMID: 4202731
  12. A plasmin-split fragment of C'3 as a new chemotactic factor.
    J Exp Med. 1967 Aug 1;126(2):189-206 PMID: 4226271
  13. The functional significance of complement.
    Adv Nephrol Necker Hosp. 1974;4:15-35 PMID: 4219991
  14. Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation.
    N Engl J Med. 1972 Oct 26;287(17):835-40 PMID: 4627271
  15. Properdin factor D: characterization of its active site and isolation of the precursor form.
    J Exp Med. 1974 Feb 1;139(2):355-66 PMID: 4855753
  16. Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation.
    J Immunol. 1973 Dec;111(6):1730-6 PMID: 4796101
  17. Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).
    J Immunol. 1973 Jan;110(1):128-38 PMID: 4734384
  18. Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein.
    Immunology. 1970 Jun;18(6):943-54 PMID: 4987909
  19. Enharncement of the hemolytic activity of the second component of human complement by oxidation.
    J Exp Med. 1967 Dec 1;126(6):1013-25 PMID: 4964564
  20. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    J Immunol. 1969 Mar;102(3):533-43 PMID: 5813010
  21. A neutrophil chemotactic factor from human C'5.
    J Immunol. 1969 Jan;102(1):93-9 PMID: 5765461
  22. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.
    J Exp Med. 1968 Apr 1;127(4):693-709 PMID: 5642465
  23. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    J Exp Med. 1967 Feb 1;125(2):359-80 PMID: 6019133
  24. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 Aug 1;122:277-98 PMID: 14316946
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1975-03-00
Pages
587-92
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC301787
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]